- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07:36 | Ikonisys: Hospitex Secures Major Public Tender for "Gaetano Martino" University Hospital in Messina | 113 | Business Wire | Regulatory News:
Hospitex, the Italian leader in the production of medical devices and a subsidiary of ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), today announces that it has... ► Artikel lesen | |
| Fr | Ikonisys SA: Ikonisys finalized a capital increase through the offsetting of debt | 196 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 31.12.24 | Ikonisys Finalized the Acquisition of Hospitex with the Issuance of 2M New Shares to ETH Scientific | 255 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 04.12.24 | The Ikonisys Group Unveils its New Vision and Strategy Under the Brand "ALIKO SCIENTIFIC" | 264 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution... ► Artikel lesen | |
| 25.11.24 | Ikonisys SA: Ikonisys Group Secures Major Public Contract for Ikoniscope20 Robotic Microscope in Italy | 57 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis... ► Artikel lesen | |
| 19.11.24 | Ikonisys SA: Ikonisys Completed a Capital Increase Through a Private Placement | 162 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| IKONISYS Aktie jetzt für 0€ handeln | |||||
| 18.11.24 | Ikonisys SA: Ikonisys Group enters Central America Market through a Partnership and Distribution Agreement with Green Med Panama | 265 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis... ► Artikel lesen | |
| 12.11.24 | Ikonisys SA: Ikonisys Group Renews Agreement as European Authorized Representative and Importer for Novodiax's CE IVD-Certified Real-Time Immunohistochemistry Technology in Oncological Diagnostics and Organ Transplant Safety | 328 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis... ► Artikel lesen | |
| 04.11.24 | Ikonisys SA: Ikonisys to Start Collaboration with SYNLAB Italy to Introduce Ikoniscope in Pathology Laboratories | 369 | Business Wire | Regulatory News:
Ikonisys (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 31.10.24 | Ikonisys SA: Ikonisys Publishes Its 2024 Half-Year Financial Results | 297 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis... ► Artikel lesen | |
| 31.10.24 | Ikonisys Publishes Its 2024 Half-Year Financial Results | 94 | Business Wire | PARIS--(BUSINESS WIRE)--Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution... ► Artikel lesen | |
| 14.10.24 | Ikonisys SA: Ikonisys Completed a Capital Increase Through a Private Placement | 449 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 10.10.24 | Ikonisys Announces That Hospitex International Won the Public Tender of the Prestigious U.O.C. Pathological Anatomy of Enna in Italy | 228 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancer through fully automated solutions for medical laboratories, is... ► Artikel lesen | |
| 03.10.24 | Successful 2024 ISO 13485 Certification Maintenance Strengthening Ikonisys' Strong Market Position and Growth Potential | 313 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 01.10.24 | Ikonisys Announces the Results of its Ordinary Annual and Extraordinary General Meeting of September 30, 2024 | 238 | Business Wire | Adoption of all resolutions submitted to the vote
Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through... ► Artikel lesen | |
| 12.09.24 | Ikonisys SA: Postponement of the Shareholders' Meeting to September 30, 2024 and Amendment of the Agenda | 210 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 11.09.24 | Ikonisys and BIO BRASIL BIOTECNOLOGIA to Strengthen Partnership to Expand Cytology Services in Brazil | 408 | Business Wire | Regulatory News:
Ikonisys (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 09.09.24 | Ikonisys SA: Ikonisys Announces the Launch of Ikoniscope Max in Europe at the 36th European Congress of Pathology in Florence | 205 | Business Wire | Regulatory News:
Ikonisys (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 04.09.24 | Ikonisys SA: Terms and Conditions of Availability of Preparatory Documents for the General Meeting of September 25, 2024 | 295 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 15.08.24 | Ikonisys SA: Ikonisys Completed a Capital Increase Through a Private Placement | 262 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen |
Seite:
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FIREFLY NEUROSCIENCE | 3,130 | 0,00 % | Firefly Neuroscience, Inc.: Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA Platform | KENMORE, N.Y., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that... ► Artikel lesen | |
| GENEDX | 72,01 | -15,29 % | GeneDx Announces Preliminary 2024 Financial Results | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for... ► Artikel lesen | |
| FRESENIUS | 35,160 | +1,01 % | EQS-News: Formycon AG: Formycon und Fresenius Kabi Canada erhalten Zulassung von Health Canada für FYB202/Otulfi® (Ustekinumab), ein Biosimilar zu Stelara® | EQS-News: Formycon AG
/ Schlagwort(e): Zulassungsgenehmigung
Formycon und Fresenius Kabi Canada erhalten Zulassung von Health Canada für FYB202/Otulfi® (Ustekinumab), ein Biosimilar... ► Artikel lesen | |
| PROGYNY | 20,030 | -1,33 % | Progyny sees Q4 results slightly above guidance ranges provided in November | ||
| NANO-X IMAGING | 7,475 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 82,00 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 51,28 | +0,43 % | Siemens Healthineers Aktie: Chancen machen Mut! | Die Siemens Healthineers-Aktie verzeichnete im XETRA-Handel einen moderaten Kursrückgang, wobei der Wert im Tagesverlauf um 0,2 Prozent auf 51,50 Euro nachgab. Trotz der aktuellen Kursschwäche zeigen... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 43,940 | +1,41 % | Fresenius Medical Care: DAX-Aufnahme treibt Bewertung: Fundamentaldaten signalisieren einen VERKAUF; mwb research empfiehlt VERKAUFEN | Fresenius Medical Care (FME) zeigte sich in den ersten neun Monaten des Jahres 2024 mit einem bereinigten Umsatzwachstum von 1% auf 14,4 Mrd EUR und einem Anstieg des operativen Ergebnisses um 21% robust... ► Artikel lesen | |
| RXSIGHT | 30,100 | -1,99 % | RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance | ALISO VIEJO, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
| CASTLE BIOSCIENCES | 25,440 | -2,72 % | Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Results | FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced certain unaudited preliminary... ► Artikel lesen | |
| ATRICURE | 34,650 | +0,76 % | AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,520 | 0,00 % | Alignment Healthcare: Stifel raises PT on strong results and tailwinds | ||
| CARL ZEISS MEDITEC | 45,280 | +0,85 % | Leichter Wertverlust bei der Carl Zeiss Meditec-Aktie (47,42 €) | Das Wertpapier von Carl Zeiss Meditec notiert heute etwas leichter. Zuletzt zahlten Investoren für das Papier 47,42 Euro. Für Inhaber von Carl Zeiss Meditec ist der heutige Handelstag bisher nicht sonderlich... ► Artikel lesen | |
| AGILON HEALTH | 2,750 | 0,00 % | Here's Why Analysts Just Upgraded Agilon Health (AGL) | ||
| TRANSMEDICS GROUP | 59,66 | -1,71 % | TransMedics Group, Inc.: TransMedics Responds to Inaccurate and Misleading Claims in Recent Short-Seller Report | ANDOVER, Mass., Jan. 13, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ... ► Artikel lesen |
Das Unternehmen IKONISYS kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +0,70 % bei einem Aktienkurs von 1,430 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IKONISYS finden Sie auf Wallstreet Online.
